Ratings for Baker Hughes BKR were provided by 16 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 8 | 6 | 2 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 6 | 4 | 1 | 0 | 0 |
| 3M Ago | 2 | 1 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $43.62, a high estimate of $50.00, and a low estimate of $38.00. Observing a 5.41% increase, the current average has risen from the previous average price target of $41.38.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Baker Hughes is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Connor Lynagh | Morgan Stanley | Lowers | Overweight | $42.00 | $43.00 |
| Josh Silverstein | UBS | Raises | Neutral | $42.00 | $40.00 |
| James West | Evercore ISI Group | Raises | Outperform | $46.00 | $42.00 |
| Marc Bianchi | TD Cowen | Raises | Buy | $50.00 | $46.00 |
| Kurt Hallead | Benchmark | Raises | Buy | $42.00 | $40.00 |
| Neil Mehta | Goldman Sachs | Raises | Buy | $43.00 | $39.00 |
| Sean Meakim | JP Morgan | Raises | Overweight | $43.00 | $42.00 |
| Lloyd Byrne | Jefferies | Raises | Buy | $48.00 | $46.00 |
| Keith Mackey | RBC Capital | Raises | Outperform | $43.00 | $39.00 |
| Roger Read | Wells Fargo | Raises | Equal-Weight | $40.00 | $35.00 |
| Charles Minervino | Susquehanna | Raises | Positive | $46.00 | $40.00 |
| Stephen Gengaro | Stifel | Raises | Buy | $45.00 | $40.00 |
| Kurt Hallead | Benchmark | Maintains | Buy | $40.00 | $40.00 |
| Saurabh Pant | B of A Securities | Lowers | Buy | $38.00 | $40.00 |
| Luke Lemoine | Piper Sandler | Lowers | Overweight | $44.00 | $45.00 |
| Lloyd Byrne | Jefferies | Raises | Buy | $46.00 | $45.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Baker Hughes. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Baker Hughes compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Baker Hughes's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Baker Hughes's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Baker Hughes analyst ratings.
Delving into Baker Hughes's Background
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. It maintains modest exposure to offshore oil and gas production. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with a high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Key Indicators: Baker Hughes's Financial Health
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Baker Hughes's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.05% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Baker Hughes's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 8.11%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Baker Hughes's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.74%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Baker Hughes's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.57% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.38.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
